Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
05/2006
05/24/2006CN1775354A Catalyst for synthesizing diphenyl methane diamino formic ether
05/24/2006CN1257153C Novel propargylether derivatives
05/23/2006US7049473 Using catalyst containing transition metal and ligand; reacting carbon monoxide and hydrogen
05/23/2006US7049460 Aromatic guanidine compound; antitumor agents; anticancer agents
05/23/2006US7049296 For therapy and prophylaxis of Alzheimer's disease
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106222 Aminoadamantane derivatives as therapeutic agents
05/18/2006US20060106204 Bifunctional energy-reversible acyl-compositions
05/17/2006EP1657243A1 Procedure for the production of amino alcohols
05/17/2006EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase
05/17/2006EP1656342A2 Process for producing optically active beta-amino acid derivatives
05/17/2006EP1656341A1 Prodrugs of 9-aminomethyl tetracycline compounds
05/17/2006EP1237847B1 Method for the stereoselective synthesis of cyclic amino acids
05/17/2006CN1774415A Carbamates useful as fragances
05/17/2006CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
05/17/2006CN1256321C Fluoroalkyloxy dispersant
05/16/2006US7045650 having good processing characteristics and physical properties even when processing time is longer than 2 minutes; includes significant amount of low cost, low monol polyoxypropylene polyol; elastomers have characteristics comparable to those produced solely with high performance polyols such as PTMEG
05/16/2006US7045579 Coating composition comprising an acetal-functional binder
05/16/2006US7045532 ACE-2 modulating compounds and methods of use thereof
05/16/2006CA2199913C Heat exchange media for the thermal cracking of carbamidic acid esters
05/11/2006WO2006048720A1 An efficient method for preparation of (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
05/11/2006WO2005033066A3 Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics
05/11/2006US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
05/11/2006US20060099159 Novel amine, amide, sulphonamide and carbamate derivatives of benzalmalonic salts and photoprotective cosmetic compositions comprised thereof
05/10/2006CN1769318A Polymeric resin compounds and their preparation
05/10/2006CN1255378C Process for preparing aryl-iminomethyl-carbamino acid esters
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006US20060091351 suitable for treating (particularly surface-treating) various substrates such as a textile; heat resistance, oxidation resistance and weather resistance
05/03/2006EP1652838A1 Diol (meth)acrylate compound having urethane bond method for producing the same and polymer thereof
05/03/2006EP1651163A2 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
05/03/2006EP1252135B8 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use
05/03/2006CN1767823A Asthma and allergic inflammation modulators
05/03/2006CN1765880A Diol (meth) acrylate compound having urethane bond, method for producing the same, and polymer thereof
05/02/2006USRE39088 Amide compounds and use of the same
05/02/2006US7038087 Process for the production of optically active amino alcohols
05/02/2006US7038078 Forming allyloxycarbonyl-, fluorenylmethoxycarbonyl-, t-butoxycarbonyl- and benzyloxycarbonyl derivatives by aziding (chloroethoxy)ethoxyethanol, reacting with triphenyl phosphine and H2O, reacting with a chloroformate, oxidizing
05/02/2006US7038077 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders
05/02/2006US7038074 Arginine mimetics as factor Xa inhibitors
05/02/2006US7038003 Polyether allophanates stable towards discolouration
05/02/2006US7037939 Compound and derivative of gabapentin
05/02/2006US7037938 For therapy of urinary incontinence
04/2006
04/27/2006WO2006044707A1 Chemical compounds
04/27/2006US20060089513 Fluorine compound and fluorinating agent comprising the compound
04/27/2006US20060089473 Diol (meth) acrylate compound having urethane bond, method for producing the same, and polymer thereof
04/27/2006US20060089336 4-Dedimethylamino tetracycline compounds
04/26/2006EP1650187A1 Optically active 2-allylcarboxylic acid derivative and process for producing the same
04/26/2006EP1648859A2 Substituted tetracycline compounds
04/26/2006CN1762990A Valency platform molecules comprising aminooxy groups
04/25/2006US7034185 Compound containing aldehyde, tertiary amine bonded to phenyl ring and a (poly)ether group; phase change ink for ink jet printers
04/25/2006US7034182 Compounds to treat Alzheimer's disease
04/25/2006US7034056 Aryl and biaryl compounds having MCH modulatory activity
04/25/2006US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors
04/25/2006US7033522 Reacting a polyisocyanate with a hydrophilicizing component; reacting free isocyanate groups with a blocking agents, and optionally neutralizing; curing agents for polyurethane and acrylic dispersions.
04/25/2006CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds
04/20/2006WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
04/20/2006US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/20/2006CA2583457A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
04/19/2006CN1761464A Substituted p-diaminobenzene derivatives
04/19/2006CN1252038C New derivatives of substituted anilines with herbicidal activity
04/18/2006US7030262 3-Amino-2-hydroxyalkanoic acids and their prodrugs
04/18/2006US7030239 Compounds to treat Alzheimer's disease
04/18/2006US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders
04/13/2006WO2006037468A1 Hiv reverse transcriptase inhibitors
04/13/2006US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/12/2006EP1644479A2 Functional synthetic molecules and macromolecules for gene delivery
04/12/2006EP1644323A2 Histone deacetylase inhibitors and methods of use thereof
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1759099A Substituted aniline derivatives
04/12/2006CN1758925A Methods of radiofluorination of biologically active vectors
04/12/2006CN1250574C Free-radical polymerised compound
04/11/2006US7026515 Optically active amine derivatives and preparation process therefor
04/11/2006US7026419 Adhesives and sealants
04/11/2006CA2217030C Protease inhibiting succinic acid derivatives
04/11/2006CA2198383C Benzene compound and pharmaceutical use thereof
04/11/2006CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them
04/06/2006WO2006035685A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same
04/06/2006US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors
04/06/2006US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/06/2006DE102004047921A1 Polyisocyanate mit sterisch anspruchsvollen Phenolen blockiert Blocked polyisocyanates with bulky phenols
04/05/2006EP1642888A1 compounds for modulating the rage receptor
04/05/2006EP1641754A1 Process and intermediates for the preparation of (1r, 2s, 5s)-3- azabicyclo[ 3, 1, 0]hexane-2-carboxamide, n- [3-amino -1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3- [ (2s)- 2-[[[1, 1-dimethylethyl ]amino]carbonyla mino ]-3, 3-dimethyl-1-oxobutyl] -6, 6-dimethyl
04/05/2006EP1140846B1 Aspartic protease inhibitors
04/05/2006EP0897747B1 Nitration or carboxylation catalysts
04/05/2006CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
04/05/2006CN1249051C Muscarinic agonists
04/05/2006CN1249024C Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
04/05/2006CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
04/04/2006US7022872 comprises intermediates such as 2-tert-butoxycarbonylamino-3-(2-fluoro-4,5-dimethoxy-phenyl)-acrylic acid ethyl ester; olefin intermediate can be stereoselectively hydrogenated to produce the R or S enantiomer
04/04/2006US7022871 Process for the synthesis of polycarbamates
04/04/2006US7022264 A solid polymer electrolyte, including a carbonate-based polymer in which a branched chain is introduced and having a high dielectric constant and a wide electrochemical stability range, having excellent processability, good safety and high ionic conductivity
04/04/2006CA2187222C Method of preparing a carbamate-or urea-functional compound
03/2006
03/30/2006CA2577799A1 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
03/29/2006EP1640361A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
03/29/2006EP1638919A1 Sphingolipids polyalkylamines conjugates
03/29/2006EP1638611A1 Sphingolipids polyalkylamine conjugates for use in transfection
03/29/2006EP1638610A1 Sphingoid polyalkylamine conjugates for vaccination
03/29/2006EP1425270B1 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors
03/29/2006CN1247541C Cyclic imines as pesticides
03/28/2006US7019173 Fluorine compound and fluorinating agent comprising the compound
03/28/2006US7019003 Bactericides
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 157